Mitchell J. Greenspan – Trademark Portfolio

Entity Type: 01

Mitchell J. Greenspan holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REPREFERRALS. The owner is based in Rye Brook, NY.

23 Berkley Lane

23 Berkley Lane

Rye Brook, NY 10573

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Mitchell J. Greenspan's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Mitchell J. Greenspan have?

Mitchell J. Greenspan has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned.

What trademark classes does Mitchell J. Greenspan file in?

Mitchell J. Greenspan files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Mitchell J. Greenspan's most well-known trademarks?

Mitchell J. Greenspan's registered trademark portfolio includes well-known marks such as REPREFERRALS. These are among 1 currently registered trademark in the portfolio.

What is Mitchell J. Greenspan's trademark registration success rate?

Mitchell J. Greenspan has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.